111 related articles for article (PubMed ID: 6826249)
21. The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients.
Mujagić Z; Mujagic H; Prnjavorac B
Med Arh; 2004; 58(1):23-6. PubMed ID: 15017899
[TBL] [Abstract][Full Text] [Related]
22. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
[TBL] [Abstract][Full Text] [Related]
23. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes in sera of dogs with benign and malignant breast disease.
Gordon BR; Moroff S; Hurvitz AI; Matus RE; MacEwen EG; Good RA; Day NK
Cancer Res; 1980 Oct; 40(10):3627-31. PubMed ID: 7438046
[TBL] [Abstract][Full Text] [Related]
26. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
27. C1q solid-phase enzymatic microassay for detection of circulating immune complexes: its application in human breast cancer.
Manzo C; Longo C; Bianchin A
Tumori; 1982 Feb; 68(1):47-52. PubMed ID: 7041380
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
Paulick R; Caffier H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
[TBL] [Abstract][Full Text] [Related]
29. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
[TBL] [Abstract][Full Text] [Related]
30. Circulating immune complexes in Hodgkin's disease.
Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
[TBL] [Abstract][Full Text] [Related]
31. [Circulating immune complex (CIC) and carcinoembryonic antigen (CEA) levels in the serum of patients with laryngeal and pharyngo-laryngeal cancer].
Basterra J; Matoses S; Aparisi M; Palop M; Marco J
An Otorrinolaringol Ibero Am; 1987; 14(3):327-36. PubMed ID: 3618980
[No Abstract] [Full Text] [Related]
32. [Circulating immune complexes in rheumatoid arthritis. Results of a personal research (author's transl)].
Kuntz JL; Pasquali JL; Thierry R; Meyer R; Vautravers P; Asch L
Sem Hop; 1979 Oct 18-25; 55(35-36):1597-600. PubMed ID: 231829
[TBL] [Abstract][Full Text] [Related]
33. A new biomarker in monitoring breast cancer: CA 549.
Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
[TBL] [Abstract][Full Text] [Related]
34. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
Paulick R; Caffier H
Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
[TBL] [Abstract][Full Text] [Related]
37. [Circulating immune complexes before and after kidney allotransplantation].
Keusch G; Vonwiller HM; von Felten A; Bammatter F; Burger HR; Largiadèr F; Binswanger U
Klin Wochenschr; 1984 Apr; 62(8):360-5. PubMed ID: 6374279
[TBL] [Abstract][Full Text] [Related]
38. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
[TBL] [Abstract][Full Text] [Related]
39. Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer.
Herberman RB; Bordes M; Lambert PH; Luthra HS; Robins RA; Sizaret P; Theofilopoulos A
Int J Cancer; 1981 May; 27(5):569-76. PubMed ID: 7287224
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
